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bjectives The aim of this study was to assess whether ultrasound attenuation and plaque rupture
s detected by intravascular ultrasound (IVUS) are associated with the incidence of no-reﬂow phe-
omenon after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial
nfarction (STEMI).
ackground No-reﬂow phenomenon is associated with worse long-term outcomes after STEMI.
herefore, reliable and feasible intravascular imaging techniques are needed to identify patient sub-
roups that would be at high risk for no-reﬂow phenomenon.
ethods One hundred seventy consecutive patients with STEMI who underwent PCI within 12 h
fter symptom onset were enrolled. The IVUS interrogation was performed before PCI.
esults No-reﬂow phenomenon occurred in 30 patients (18%), who had a higher incidence of no
T-segment resolution (50% vs. 9%; p  0.001), a higher peak creatine kinase level (4,090 IU/l vs.
,823 IU/l; p  0.001), and a lower left ventricular ejection fraction in the chronic phase (51% vs.
9%; p  0.01). Multivariate logistic regression analysis revealed that ultrasound attenuation with a
ongitudinal length of 5 mm, plaque rupture, and reperfusion time correlated with no-reﬂow
henomenon (all p  0.05). In patients with both ultrasound attenuation 5 mm and plaque rup-
ure, the incidence of no-reﬂow phenomenon was 88%, and the risk of decreased coronary reﬂow
as higher than that predicted by either factor alone (p  0.004 for interaction).
onclusions In patients with STEMI, a longer ultrasound attenuation and plaque rupture on IVUS
re associated with an increased incidence of no-reﬂow phenomenon, suggesting that this subset of
atients might be at high risk for distal embolism. (J Am Coll Cardiol Intv 2010;3:540–9) © 2010 by
he American College of Cardiology Foundation
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541arly and sustained restoration of adequate antegrade reflow
n the infarct-related artery has been the primary objective
f reperfusion therapy in patients with ST-segment eleva-
ion myocardial infarction (STEMI) (1). Percutaneous cor-
nary intervention (PCI) has become an established reper-
usion strategy for the treatment of STEMI, because of a
igher recanalization rate and less residual stenosis as
ompared with thrombolysis (2). Nevertheless, microemboli
f atherosclerotic plaque debris and thrombus can cause
icrovascular damage during balloon inflation or stent
eployment (3), resulting in a no-reflow phenomenon,
haracterized by inadequate reflow at the microvascular level
espite a reopened epicardial coronary artery (4). Recent
tudies have reported that angiographic no-reflow phenom-
na are associated with worse long-term outcomes after
TEMI (5,6).
Recent reports suggested that atherosclerotic plaque with
ltrasound attenuation might be related to the deterioration
f coronary flow (7) and a larger infarct size as well as a
igher incidence of fatal arrhythmias after PCI in patients
ith acute coronary syndrome (8). By contrast, we have
reviously reported that plaque rupture in the culprit
esion for anterior STEMI is associated with a larger infarct
ize than the absence of plaque rupture, suggesting that
reater plaque embolism might occur after PCI in patients
ith plaque rupture (9). Therefore, we proposed that
ltrasound attenuation and plaque rupture as detected by
ntravascular ultrasound (IVUS) before PCI might be useful
haracteristics for the prediction of no-reflow phenomenon
fter PCI in patients with STEMI. To test this hypothesis,
e investigated the association between the morphologic
haracteristics of culprit lesions on IVUS and angiographic
o-reflow phenomenon.
ethods
tudy population. Patients with a first STEMI who under-
ent IVUS interrogation before PCI were eligible for
nrollment. All patients were treated by stent deployment
ithin 12 h after the onset of symptoms. We excluded
atients with cardiogenic shock, those with concomitant
evere diseases such as malignant disease, those who used
ny distal protection device or aspiration device, and those
ith culprit lesions in the left main trunk. We enrolled 170
onsecutive patients with STEMI who met all inclusion
riteria. A diagnosis of acute myocardial infarction required
he presence of continuous chest symptoms for more than
0 min, ST-segment elevation of 0.1 mV in 2 limb leads
r 0.2 mV in 2 contiguous precordial leads, and a rise in
erum creatine kinase (CK) levels to more than twice the
pper limit of normal.
The study protocol was approved by the ethics committeef Yokohama City University Medical Center. Written pnformed consent was obtained from all participants before
nitial coronary angiography.
tudy protocol. All patients were given 200 mg of aspirin,
n intravenous injection of 4,000 IU heparin, and 2 mg of
sosorbide dinitrate immediately after diagnosis of STEMI.
n the absence of contraindications cited in the American
ollege of Cardiology/American Heart Association practice
uidelines (10), facilitated PCI preceded by early treatment
ith a half-dose of fibrinolytics was performed before
lanned PCI. Glycoprotein IIb/IIIa inhibitors were not
sed because these drugs were not approved in Japan. In the
atheterization laboratory, intravenous heparin was given to
aintain an activated clotting time of 300 s during the
rocedure, and intracoronary isosorbide dinitrate (2 to 2.5
g) was administered before angiography and after careful
anipulation of the guidewire.
efore any balloon inflation or
tent implantation, a 40-MHz
VUS catheter (Boston Scientific,
oston, Massachusetts) was ad-
anced distal to the culprit lesion,
nd IVUS examination was per-
ormed with an automated pull-
ack speed of 0.5 mm/s. While
ulling back the catheter, we
anually infused contrast me-
ium or normal saline suitable for
VUS imaging and carefully ob-
erved the lesion. This procedure
nabled us to eliminate blood
oise and to observe communica-
ion between the plaque and the
oronary artery lumen.
After pre-interventional IVUS,
CI was performed with a con-
entional technique. Decision
aking related to the PCI strat-
gy was left to the discretion of
he individual PCI cardiologist.
ngiographic analysis. Coronary angiography was per-
ormed with a frame rate of 15/s. Quantitative coronary
ngiography was performed with an automated edge detec-
ion system (MEDIS CMS, Leiden, the Netherlands).
hrombolysis In Myocardial Infarction (TIMI) flow grade
as assessed as described previously (11). No-reflow phe-
omenon was defined as TIMI flow grade 0, 1, or 2 without
echanical obstruction on the angiogram immediately after
tent deployment. Corrected Thrombolysis In Myocardial
nfarction frame count (CTFC) was also measured imme-
iately after stenting to objectively evaluate coronary reflow,
s described by Gibson et al. (12). The number of frames
as multiplied by 30 and divided by 15 to report a cine
rame count in accordance with standard methods. In
Abbreviations
and Acronyms
CI  confidence interval
CK  creatine kinase
CSA  cross-sectional area
CTFC  corrected
Thrombolysis In Myocardial
Infarction frame count
EEM  external elastic
membrane
IVUS  intravascular
ultrasound
LV  left ventricular
OR  odds ratio
PCI  percutaneous
coronary intervention
PM  plaque plus media
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial Infarctionatients with TIMI flow grade 0 or 1 after PCI, a CTFC of
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54200 was used. Collateral flow was graded according to the
entrop classification (13). Thrombus seen on angiogram
as defined as TIMI thrombus grade 2 (14).
lectrocardiographic and cardiac enzyme analyses. A 12-
ead electrocardiogram was recorded on admission and 1 h
fter the final angiogram, at a paper speed of 25 mm/s and
n amplification of 10 mm/mV. The sum of ST-segment
levation in leads V1 to V6, I, and aVL for anterior
nfarctions and leads II, III, aVF, and V5 to V6 for
onanterior infarctions on electrocardiograms obtained 1 h
fter the final angiogram was compared with the value on
dmission. The ST-segment resolution was categorized as
omplete (70%), partial (30% to 70%), or absent (30%).
Blood samples were obtained on admission, at 3-h
ntervals during the first 24-h, and at 6-h intervals for the
ext 2 days after PCI. These samples were analyzed to
erive peak CK levels.
eft ventriculogram. We performed left ventriculography
uring the chronic phase after STEMI (mean 192  31
ays). Right anterior oblique views of left ventriculograms
ere used to measure the left ventricular (LV) ejection
raction. End-diastolic and end-systolic endocardial borders
ere hand-traced in the frames with maximal and minimal
olumes, and end-diastolic and -systolic volumes were
alculated by the area-length method.
VUS analysis. The arc of backward signal attenuation with-
ut dense calcium was measured in degrees with a protractor
entered on the lumen. Backward signal attenuation was
hen classified as 1-quadrant (90°), 2-quadrant (90° to
79°), 3-quadrant (180° to 269°), or 4-quadrant (270° to
60°) attenuation. Plaque rupture was defined as reported
reviously (9,15): 1) plaque ulceration with a tear detected
Figure 1. Typical Intravascular Ultrasound Images of Plaque Rupture
Typical pre-interventional intravascular ultrasound image of plaque rupture (A
communication between the cavity of the rupture (R) and the lumen can be on a fibrous cap; or 2) lesions without plaque ulceration but Cn which the injection of saline or contrast medium con-
rmed communication between the plaque and the coronary
rtery lumen (Fig. 1). A lipid pool-like image was defined as
pooling of low-echoic material or echolucent material
overed with a high-echoic layer (16). Calcium was brighter
han the adventitia with an arc of 90° of acoustic shad-
wing. The location of calcium was defined as superficial
the leading edge of the acoustic shadowing appears within
he shallowest 50% of the plaque plus media [PM]
hickness) or deep (the leading edge of the acoustic shad-
wing appears within the deepest 50% of the PM
hickness).
Quantitative analysis was performed according to the
merican College of Cardiology clinical expert consensus
ocument on IVUS (15). External elastic membrane
EEM) cross-sectional area (CSA), PM CSA, and lumen
SA at the reference and lesion sites were analyzed with
lanimetry software (TapeMeasure, Indec Systems, Capi-
ola, California). If EEM circumference could not be
dentified because of attenuation, we interpolated the EEM
rea (7). Remodeling was positive when the lesion EEM
SA was greater than both the proximal and distal refer-
nce EEM CSA (17). The length (in millimeters) of
ltrasound attenuation was measured from the number of
econds of videotape in which ultrasound attenuation was
dentified (millimeters seconds of videotape 0.5 mm/s).
otal plaque volume was calculated as the sum of PM
SA at 1-mm axial intervals for the IVUS images from a
esion segment of 20 mm, centered on the smallest pre-
ntervention lumen CSA.
tatistical analysis. Statistical analysis was performed with
tatView version 5.0 software (SAS Institute, Cary, North
ushing saline (B), plaque ulceration with a ﬁbrous cap (arrowheads) and a
d more clearly.). By ﬂarolina). Results of continuous variables are reported as mean
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543D. Qualitative data are presented as n (%). Continuous
ariables were compared by means of Student t test, and
ategorical data were compared by the chi-square test or
isher exact test. Intraobserver and interobserver agree-
ents were measured by calculating Cohen’s kappa value. A
appa value of 0.61 to 0.80 indicates good agreement, and
value of 0.81 to 1.0 indicates excellent agreement. Pear-
on’s correlation analysis was performed to evaluate the
elation between length of ultrasound attenuation and
TFC after PCI. To determine the optimal threshold of
he length of ultrasound attenuation for the prediction of
o-reflow phenomenon, receiver-operating characteristics
urve analysis was applied. The cutoff point was defined as
he greatest sum of the sensitivity and specificity estimates.
ssociations between the occurrence of no-reflow phenom-
non and clinical variables were assessed by multivariate
ogistic regression analysis. Only significant variables on the
nivariate analysis were included in the multivariate analy-
is, except for EEM CSA at the lesion and reference sites,
hich were excluded because they strongly correlated with
otal plaque volume. An F test was used to test for the
resence of interactions between IVUS morphological find-
ngs on CTFC after PCI. For all analyses, values of p 
.05 were considered to indicate statistical significance.
esults
eproducibility of data. We assessed reproducibility of the
ngiographic and IVUS findings in a random sample of 30
atients. Coronary angiograms were reviewed separately by
independent observers blinded to the clinical and IVUS
ndings. Intraobserver variability was 0.16  0.27 mm for
eference vessel diameter and 2.4  1.5 frames for CTFC.
nterobserver variability was 0.19  0.25 mm for reference
essel diameter and 2.1 1.7 frames for CTFC. The kappa
alues for intraobserver and interobserver agreements of
IMI flow grade were 0.91 and 0.86, respectively. The
iagnosis of morphological features on IVUS images re-
uired an independent review and agreement by 2 experi-
nced observers who were blinded to the clinical and
ngiographic information. On assessment of intraobserver
greement, the kappa value was 0.93 for ultrasound atten-
ation and 0.87 for plaque rupture. On assessment of
nterobserver agreement, the kappa value was 0.92 for
ltrasound attenuation and 0.86 for plaque rupture.
atient characteristics and angiographic ﬁndings. No-reflow
henomenon immediately after stent deployment was ob-
erved in 30 of 170 patients (18%), including 14 patients in
hom TIMI flow grade 3 was achieved after intracoronary
dministration of nicorandil and the use of intra-aortic
alloon pumping. Patients were classified according to coro-
ary reflow after PCI: 30 patients had TIMI flow grade 0, 1,
r 2 (no-reflow group); and 140 patients had TIMI flow grade
(reflow group). Baseline clinical characteristics and angio- wraphic findings are summarized in Table 1. There were no
ifferences between the groups in age, sex, incidence of
oronary risk factors, Killip class 2, facilitated PCI with
brinolytics, or pre-infarction angina. Reperfusion time (4.0
.3 h vs. 3.1  1.9 h; p  0.02) was longer in the no-reflow
roup than in the reflow group. Angiographic findings and
CI procedural data were similar in the groups.
omparison of ST-segment resolution after PCI, infarct size, and
V function in the chronic phase between no-reﬂow and reﬂow
roups. The ST-segment resolution after PCI, peak CK
evels, and left ventriculographic findings in the chronic phase
Table 1. Baseline Characteristics of the Patients
No-Reflow Group
(n  30)
Reflow Group
(n  140) p Value
Clinical
Age, yrs 65 11 63 11 0.34
Men 21 (70) 114 (81) 0.18
Coronary risk factors
Systemic hypertension 16 (53) 86 (61) 0.41
Diabetes mellitus 6 (20) 36 (26) 0.51
Smoking 20 (67) 99 (71) 0.66
Hypercholesterolemia 17 (57) 73 (52) 0.65
Killip class 2 3 (10) 7 (5) 0.38
Facilitated PCI with ﬁbrinolytics 16 (53) 89 (65) 0.30
Pre-infarction angina 14 (47) 55 (39) 0.46
Reperfusion time, h 4.0 2.3 3.1 1.9 0.02
Angiographic
Infarct-related artery 0.87
Left descending artery 14 (47) 72 (51)
Left circumﬂex artery 3 (10) 11 (8)
Right coronary artery 13 (43) 57 (41)
Diseased vessel 2 6 (20) 54 (39) 0.05
Baseline TIMI ﬂow grade 0.73
0/1 19 (63) 80 (57)
2 4 (13) 27 (19)
3 7 (23) 33 (24)
CTFC after PCI 65.8 23.8 22.5 8.2 0.001
Collateral ﬂow grade 2 14 (47) 73 (52) 0.59
Reference vessel diameter, mm 3.07 0.46 3.01 0.46 0.47
Minimal lumen diameter, mm 0.42 0.58 0.53 0.63 0.38
Diameter stenosis, % 86.2 19.4 81.5 21.7 0.27
Thrombus 17 (57) 77 (55) 0.88
IABP use 2 (7) 3 (2) 0.21
Procedural
Stent/artery ratio 1.18 0.15 1.17 0.15 0.72
Stent size, mm 3.50 0.49 3.46 0.43 0.67
Stent length, mm 17.7 4.4 18.1 4.1 0.64
Direct stenting 6 (20) 45 (32) 0.19
Maximum inﬂation pressure, atm 14.6 2.5 14.7 2.1 0.97
Data are presented as mean SD or n (%).
CTFC  corrected Thrombolysis In Myocardial Infarction frame count; IABP  intra-aortic
balloon pumping; PCIpercutaneous coronary intervention; TIMI Thrombolysis InMyocardial
Infarction.ere compared between the no-reflow and the reflow groups
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544Table 2). The ST-segment resolution was absent in 15 of the
0 patients (50%) in the no-reflow group and 13 of the 140
9%) in the reflow group (p  0.001). The peak CK level was
igher (4,090  2,354 IU/l vs. 2,823  1,692 IU/l; p 
.001), the LV ejection fraction at follow-up was lower (51 
3% vs. 59 10%; p 0.01), and the LV end-systolic volume
ndex at follow-up was greater (38  23 ml/m2 vs. 27  12
l/m2; p 0.01) in the no-reflow group than in the reflow group.
he incidence of no-reﬂow phenomenon and the arc of
ackward signal attenuation on IVUS. The incidences of
o-reflow phenomenon in patients with 1-, 2-, 3-, and
-quadrant attenuation were 10%, 10%, 33%, and 33%,
Table 2. ST-Segment Resolution After PCI, Infarct Si
ST-segment resolution after PCI
Complete/partial
Absent
Peak creatine kinase levels, IU/l
Left ventriculogram ﬁndings in the chronic phase
Ejection fraction, %
LVESVI, ml/m2
LVEDVI, ml/m2
Data are presented as mean SD or n (%).
LV left ventricular; LVEDVI left ventricular end-diastolic volume i
as in Table 1.
Table 3. Pre-Intervention IVUS Findings
IVUS images
Plaque rupture
Lipid pool-like image
Superﬁcial calcium
Deep calcium
Arc of backward signal attenuation
0–89° (1-quadrant)
90–179° (2-quadrant)
180–269° (3-quadrant)
270–360° (4-quadrant)
Ultrasound attenuation*
IVUS measurements
EEM CSA at the proximal reference site, mm2
EEM CSA at the lesion site, mm2
Lumen CSA at the lesion site, mm2
EEM CSA at the distal reference site, mm2
Total plaque volume, mm3
Remodeling index
Positive remodeling
Data are presented as mean  SD or n (%). *Ultrasound attenuation
attenuation of180° behind plaque without dense calcium.CSA cross-sectional area; EEM external elastic membrane.espectively. The incidence of no-reflow phenomenon was
ignificantly higher in the patients with 3- and 4-quadrant
ttenuation than in the other groups but was similar in
atients with 1-quadrant attenuation and those with
-quadrant attenuation. Therefore, ultrasound attenua-
ion was defined as IVUS images with backward signal
ttenuation of 180° behind plaque without dense cal-
ium (Table 3, Fig. 2).
re-intervention IVUS ﬁndings. The morphological and
uantitative IVUS findings are summarized in Table 3.
ulprit lesions in the no-reflow group had significantly
igher prevalence of plaque rupture (87% vs. 51%, p  0.001)
d LV Function in the Chronic Phase
eflow Group
n  30)
Reflow Group
(n  140) p Value
0.001
15 (50) 127 (91)
15 (50) 13 (9)
90 2,354 2,823 1,692 0.001
51 13 59 10 0.01
38 23 27 12 0.01
73 29 65 18 0.10
ESVI left ventricular end-systolic volume index; other abbreviations
flow Group
 30)
Reflow Group
(n  140) p Value
26 (87) 71 (51) 0.001
14 (47) 77 (55) 0.41
3 (10) 39 (28) 0.07
7 (23) 21 (15) 0.28
0.01
6 (20) 56 (40)
5 (17) 46 (33)
13 (43) 26 (19)
6 (20) 12 (9)
19 (63) 38 (27) 0.001
.7 4.8 15.0 4.3 0.01
.4 4.6 14.6 3.9 0.001
.3 0.7 2.4 1.0 0.66
.0 4.2 12.9 4.0 0.16
0 59 167 51 0.01
1 0.23 1.07 0.23 0.31
13 (43) 62 (44) 0.92
ned as intravascular ultrasound (IVUS) images with backward signalze, an
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545nd ultrasound attenuation (180° backward signal attenua-
ion) (63% vs. 27%, p  0.001) compared with those in the
eflow group. The incidence of lipid pool-like image and
alcium was similar in the groups. The EEM CSA at the
roximal reference site (17.7  4.8 mm2 vs. 15.0  4.3 mm2;
 0.01) and EEM CSA at the lesion site (17.4  4.6 mm2
s. 14.6  3.9 mm2; p  0.001) were larger, and total plaque
olume (200  59 mm3 vs. 167  51 mm3; p  0.01) was
reater in the no-reflow group than in the reflow group.
VUS measurements of atherosclerotic plaque with ultra-
ound attenuation. Among the 170 patients, 57 (34%) had
ltrasound attenuation in their culprit lesions. Atheroscle-
otic plaque with ultrasound attenuation had a larger EEM
SA at the lesion site (15.9 4.3 mm2 vs. 14.7 4.1 mm2;
 0.07), a smaller lumen CSA (2.1  0.6 mm2 vs. 2.5 
.0 mm2; p  0.01), a greater total plaque volume (187 
4 mm3 vs. 166  53 mm3; p  0.02), and a higher
emodeling index (1.13  0.24 vs. 1.04  0.22; p  0.01)
han atherosclerotic plaque without ultrasound attenuation.
he incidence of angiographic thrombus, plaque rupture,
nd lipid pool-like images was similar in patients with and
hose without ultrasound attenuation (data not shown).
mpact of ultrasound attenuation on the incidence of no-
eﬂow phenomenon. Patients with ultrasound attenuation
Figure 2. Typical Intravascular Ultrasound Images of Ultrasound Attenuatio
A longitudinal view (upper panel) shows that ultrasound attenuation is distrib
A, B, C) correspond to the sections (upper panel A, B, C) indicated by the br
behind plaque without dense calcium is observed (B).ad a higher incidence of no-reflow phenomenon than shose without ultrasound attenuation (33% vs. 10%; p 
.001). Among the 57 patients with ultrasound attenuation,
he length of ultrasound attenuation strongly correlated
ith CTFC after PCI (r  0.61, p  0.0001) (Fig. 3). The
eceiver-operating characteristics curve showed that 5 mm
as the optimal threshold of the length of ultrasound
ttenuation to predict no-reflow phenomenon. The use of
his value yielded a sensitivity of 79% and a specificity of
4% (Fig. 4). According to this threshold, we divided the
atients with ultrasound attenuation into 2 groups: those
ith ultrasound attenuation 5 mm (n  21) and those
ith ultrasound attenuation 5 mm (n  36). The inci-
ence of no-reflow phenomenon was higher in patients with
ltrasound attenuation 5 mm than in those either with
ltrasound attenuation5 mm (71% vs. 11%; p 0.001) or
ithout ultrasound attenuation (71% vs. 10%; p  0.001).
he incidence of no-reflow phenomenon was similar in
atients with ultrasound attenuation 5 mm and in those
ithout ultrasound attenuation.
eterminants of no-reﬂow phenomenon. Independent pre-
ictors related to the occurrence of no-reflow phenomenon
ere determined by multiple logistic regression analysis, in
hich ultrasound attenuation with a longitudinal length of
5 mm, plaque rupture, total plaque volume, and reperfu-
continuously along the coronary vessel. Cross-sectional views (lower panel
white lines on the longitudinal views. Backward signal attenuation 180°n
uted
okenion time were entered. Multivariate analysis confirmed
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546ltrasound attenuation with a longitudinal length of 5
m (odds ratio [OR]: 20.1, 95% confidence interval [CI]:
.87 to 69.0; p 0.001), plaque rupture (OR: 5.94, 95% CI:
.64 to 21.5; p  0.01), and reperfusion time (per hour)
OR: 1.26, 95% CI: 1.00 to 1.58; p 0.047) as independent
redictors of no-reflow phenomenon.
Figure 3. Correlation Between Length of Ultrasound Attenuation and
CTFC After PCI
Length of ultrasound attenuation strongly correlated with corrected Throm-
bolysis In Myocardial Infarction frame count (CTFC) after percutaneous cor-
onary intervention (PCI). In patients with Thrombolysis In Myocardial
Infarction ﬂow grade 0 or 1 after PCI, CTFC of 100 was used.
Figure 4. ROC Curve to Determine the Optimal Cutoff Value for the
Length of Ultrasound Attenuation to Predict No-Reflow Phenomenon
The optimal cutoff point for the length of ultrasound attenuation was
5 mm with a sensitivity of 79% and speciﬁcity of 84%. ROC  receiver-t
operating characteristics.We analyzed the data by stratifying patients according to
ge, reperfusion time, infarct-related artery, TIMI flow
rade at initial angiography, thrombus seen on angiogram,
eference vessel diameter, high-pressure stenting, and facil-
tated PCI with fibrinolytics (Table 4). In all subgroups, the
requencies of no-reflow phenomenon were still signifi-
antly higher in patients with ultrasound attenuation 5
m than in those with ultrasound attenuation 5 mm or
ithout ultrasound attenuation.
ffect of interaction between ultrasound attenuation and
laque rupture on coronary reﬂow after PCI. Potential in-
eractions between ultrasound attenuation 5 mm and
laque rupture were assessed with respect to their effect on
oronary reflow after PCI. There was a statistically signifi-
ant interaction between ultrasound attenuation 5 mm
nd plaque rupture as related to CTFC after PCI (p 
.004 for interaction). Thus, patients with both ultrasound
ttenuation 5 mm and plaque rupture had higher CTFC
fter PCI (66.1  29.4) than that expected from the sum of
Table 4. Valuation of the Incidence of No-Reflow Phenomenon in
Each Subgroup
Subgroups
Ultrasound Attenuation >5 mm
With Without p Value
Age, yrs
65 11/16 5/65 0.001
65 4/5 10/84 0.01
Reperfusion time, h
6 4/4 2/13 0.01
6 11/17 13/136 0.001
Infarct-related artery
RCA 5/9 8/61 0.01
LAD/LCX 10/12 7/88 0.001
TIMI ﬂow grade at initial angiogram
0 or 1 7/10 12/89 0.001
2 3/4 1/27 0.01
3 5/7 2/33 0.01
Thrombus seen on angiogram
Yes 9/10 8/84 0.001
No 6/11 7/65 0.01
Reference vessel diameter, mm
3.0 7/10 9/73 0.001
3.0 8/11 6/76 0.001
High-pressure (16 atm) stenting
Yes 8/9 7/72 0.001
No 7/12 8/77 0.001
Facilitated PCI with ﬁbrinolytics
Yes 11/17 5/88 0.001
No 4/4 10/61 0.01
Data are presented as number/total of patients.
LAD  left anterior descending artery; LCX  left circumflex coronary artery; RCA  right
coronary artery; other abbreviations as in Table 1.he individual effects of these factors. In this subset of 16
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547atients, the frequency of no-reflow phenomenon was 88%,
hich was higher than that of any other subset of patients
Fig. 5).
iscussion
he principal finding of the present IVUS study was that
onger ultrasound attenuation without dense calcification
nd plaque rupture at culprit lesions were strongly associated
ith no-reflow phenomenon in patients with STEMI. In
ddition, a significant interaction was observed between
onger ultrasound attenuation and plaque rupture, which
as associated with diminished coronary reflow as assessed
y CTFC after PCI, suggesting that lesions with both
onger ultrasound attenuation and plaque rupture had the
ighest risk of no-reflow phenomenon.
Previous studies have shown that abnormalities at the
evel of the microvasculature cause no-reflow phenomenon
18,19). Various factors have been proposed as determinants
f microvascular damage, including the generation of oxy-
en free radicals, tissue edema, endothelial dysfunction,
eutrophil plugging of microvessels, vasoconstriction, and
istal embolism (20). Regardless of the underlying causes,
o-reflow phenomenon is related to long-term mortality in
atients with STEMI (5,6). In the present study, no-reflow
henomenon was associated with the absence of ST-
egment resolution after PCI, larger infarct size, and lower
V ejection fraction in the chronic phase, consistent with
he results of previous studies (5,6,16).
No-reflow phenomenon is a process that starts during the
Figure 5. Three-Dimensional Representation of No-Reflow Phenomenon
Rate in Relation to Ultrasound Attenuation and Plaque Rupture
In patients with both ultrasound attenuation 5 mm and plaque rupture,
the risk for no-reﬂow phenomenon was higher than that in any other sub-
set of patients.schemic period and then increases during reperfusion. trolonged ischemia and delayed reperfusion can cause
hanges in endothelial cells and lead to extensive microvas-
ular dysfunction (21). In the present study, reperfusion
ime was an independent predictor of no-reflow phenome-
on. Reperfusion-related injury can also disrupt the coro-
ary microcirculation, resulting in expansion of the no-
eflow phenomenon. In addition, distal atherothrombotic
mbolization contributes to microvascular injury to some
xtent, particularly during PCI. In the present study, 7
atients with no-reflow phenomenon had normal coronary
ow (TIMI flow grade 3) at baseline that deteriorated
mmediately after stent deployment. In these patients, distal
mbolism during PCI probably increased microvascular
amage, subsequently leading to diminished coronary flow
fter PCI. In patients with STEMI, a high atherothrom-
otic burden and a decrease in plaque volume as assessed by
VUS during PCI have a negative impact on coronary
eflow after PCI (22,23). Recent IVUS studies showed that
therosclerotic plaque with ultrasound attenuation might be
elated to the deterioration of coronary flow in patients with
cute coronary syndrome (7,8). These studies suggested that
of the mechanisms of no-reflow phenomenon was micro-
ascular dysfunction resulting from distal embolism of
laque contents induced by PCI.
Recently, several studies have investigated the pathology
f ultrasound attenuation without dense calcification in
oronary plaque. In a study of autopsy specimens of human
oronary arteries, Hara et al. (24) showed that ultrasound
ttenuation was associated with fibrofatty tissue containing
cattered cholesterol clefts and Von Kossa-positive granules
orresponding to microcalcification, which caused ultra-
ound wave reflection and dispersion. Histopathological
xamination of coronary plaque obtained by directional
therectomy demonstrated that hyalinized fibrous plaque
nd expansive remodeling were related to images with
ackward ultrasound attenuation (25). Another histological
tudy of human cadaveric coronary arteries revealed that
brofatty plaque and a necrotic core were more frequently
ound in attenuated plaque (26). In addition, Johnstone et
l. (27) reported that white thrombi produced by blood from
abbits might cause backscattered energy attenuation, sug-
esting that thrombus has a role in ultrasound attenuation.
n the present study, we demonstrated that vessel size and
laque thickness were related to the formation of ultrasound
ttenuation. Taken together, available evidence suggests
hat tissue characteristics, including cholesterol clefts and
icrocalcification, and white thrombus as well as plaque
urden play important roles in producing ultrasound atten-
ation in the setting of STEMI.
We previously reported that plaque rupture was related to
arger infarcts, a higher incidence of no-reflow phenome-
on, and long-term decreased LV function in patients with
nterior STEMI (9). In the current study, we demonstrated
hat the frequency of no-reflow phenomenon in patients
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548ith both ultrasound attenuation 5 mm and plaque
upture was 88%. With angioscopy, Mizote et al. (3)
howed that microcirculatory damage after PCI was more
requent among patients with ruptured plaque than among
hose without ruptured plaque. It is plausible that compo-
ents of atherosclerotic plaque with ultrasound attenuation
re easily released into the coronary circulation during PCI
hrough the “rupture hole” in patients with plaque rupture.
Conventional 40-MHz gray-scale IVUS has been used
hroughout the world as an intravascular imaging technique
uring PCI. Therefore, prediction of no-reflow phenome-
on with 40-MHz gray-scale IVUS might have a substan-
ial impact on decision making in the catheterization labo-
atory. Although several trials have been conducted with a
ariety of embolic protection devices, conflicting results
ave cast doubt on whether the routine use of embolic
rotection devices is warranted (28). Therefore, the selective
se of embolic protection devices for the patients at high
isk for distal embolization during PCI might be an attrac-
ive option.
tudy limitations. The findings of the present study have to
e interpreted in the context of the following limitations.
irst, this was a retrospective observational analysis from a
ingle center. Further prospective studies are warranted to
nvestigate the interaction between IVUS parameters and
oronary flow to elucidate the mechanisms of no-reflow
henomenon. Second, because IVUS findings were ob-
ained with a 40-MHz IVUS transducer, our results must
e interpreted with caution, especially when extrapolating
ur findings to other IVUS systems. Third, the true inci-
ence of plaque rupture might have been underestimated,
ecause thrombi overlying plaque-rupture sites obscure
ssures, dissections, or communications between the plaque
nd the coronary artery lumen on pre-interventional IVUS.
evertheless, our results would be strengthened further if
uptured plaque with increased thrombus burden was mis-
nterpreted to be nonruptured plaque. Fourth, because we
ncluded patients with STEMI who were treated by PCI
ithin 12 h after symptom onset, our findings are not
pplicable to patients with STEMI treated more than 12 h
fter symptom onset or to patients with angina pectoris.
ifth, Doppler measurements of coronary flow velocity
atterns and coronary flow reserve might be more useful for
he assessment of coronary reflow and microvascular func-
ion than TIMI flow grade and CTFC (29). Sixth, the use
f fibrinolytics might have affected our results. Although the
ubgroup analysis demonstrated that the frequencies of
o-reflow phenomenon in the presence of long ultrasound
ttenuation were significantly higher than those in the
bsence of long ultrasound attenuation, irrespective of the
se of fibrinolytics, our observations need to be confirmed in
atients who receive primary PCI alone. Seventh, glyco-
rotein IIb/IIIa inhibitors were not approved in Japan at the
ime of this study, excluding potential effects of these drugsn the incidence of no-reflow phenomenon. Finally, mul-
ivariate modeling with a relatively small number of events
s subject to overfitting, although an attempt was made to
imit the number of variables entered for adjustment. Thus,
ur results should be considered hypothesis-generating.
onclusions
n the setting of STEMI, the presence of longer ultrasound
ttenuation and plaque rupture as assessed by pre-
nterventional IVUS is associated with a higher incidence of
o-reflow phenomenon after PCI. Further studies are re-
uired to clarify whether pharmacologic or mechanical
ntervention can reduce no-reflow phenomenon in this
ubset of patients at high risk.
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